Catriona Yale Akero Therapeutics, Inc. (AKRO) insider trading activity

AKRO Quotes by TradingView

Catriona Yale is Chief Development Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 74,158 shares of AKRO, which is worth approximately $2.43 Million. The most recent transaction as insider was on Jun 30, 2022, when has been sold 1,152 shares (Common Stock) at a price of $8.03 per share, resulting in proceeds of $9,251. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.2K
2.34% 3M change
61.18% 12M change
Total Value Held $2.43 Million

Catriona Yale Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2022
BUY
Grant, award, or other acquisition
$9,251 $8.03 p/Share
1,152 Added 0.93%
122,073 Common Stock
Oct 15 2021
SELL
Open market or private sale
$274,500 $21.96 p/Share
12,500 Reduced 9.37%
120,921 Common Stock
Sep 15 2021
SELL
Open market or private sale
$311,750 $24.94 p/Share
12,500 Reduced 8.57%
133,421 Common Stock
Aug 16 2021
SELL
Open market or private sale
$187,900 $18.79 p/Share
10,000 Reduced 6.41%
145,921 Common Stock
Jul 15 2021
SELL
Open market or private sale
$209,000 $20.9 p/Share
10,000 Reduced 6.03%
155,921 Common Stock
Jun 30 2020
BUY
Grant, award, or other acquisition
$21,252 $17.07 p/Share
1,245 Added 0.75%
164,914 Common Stock
CY

Catriona Yale

Chief Development Officer
South San Francisco, CA

Track Institutional and Insider Activities on AKRO

Follow Akero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKRO shares.

Notify only if

Insider Trading

Get notified when an Akero Therapeutics, Inc. insider buys or sells AKRO shares.

Notify only if

News

Receive news related to Akero Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKRO